{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T16:48:47Z","timestamp":1774802927221,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109058","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:01:36Z","timestamp":1759158096000},"page":"109058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel 2,6-Bis(indolyl\/ 5-bromoindolyl)dihydropyridine\/pyridine hybrids as potential anti-tumor agents: Design, one-pot Green synthesis, molecular docking, and cytotoxicity evaluation"],"prefix":"10.1016","volume":"166","author":[{"given":"Norhan K.","family":"Hasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal M.","family":"Kandeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.F.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman A.","family":"El-Khouly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109058_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med"},{"issue":"2021","key":"10.1016\/j.bioorg.2025.109058_bb0010","first-page":"7","article-title":"Cancer statistics","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.109058_bb0015","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.109058_bb0020","author":"Rajput"},{"key":"10.1016\/j.bioorg.2025.109058_bb0025","first-page":"54","article-title":"Historical review of the causes of cancer, world","volume":"7","author":"Blackadar","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109058_bb0030","series-title":"Indole Derivatives as Potential Anticancer Agents: A Review","author":"Sachdeva","year":"2020"},{"key":"10.1016\/j.bioorg.2025.109058_bb0035","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4103\/ijc.IJC_83_21","article-title":"Breast cancer surpasses lung cancer as the most commonly diagnosed cancer worldwide","volume":"59","author":"Bashar","year":"2022","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.bioorg.2025.109058_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bioorg.2025.109058_bb0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.critrevonc.2010.01.010","article-title":"Colon cancer","volume":"74","author":"Labianca","year":"2010","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bioorg.2025.109058_bb0050","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis","volume":"59","author":"Stanca Melincovici","year":"2018","journal-title":"Romanian J. Morphol. Embryol."},{"key":"10.1016\/j.bioorg.2025.109058_bb0055","first-page":"1097","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-Angiogenic therapies, genes","volume":"2","author":"Shibuya","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2025.109058_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10456-006-9055-8","article-title":"Vascular endothelial growth factor receptor-1 (VEGFR-1\/Flt-1): a dual regulator for angiogenesis","volume":"9","author":"Shibuya","year":"2006","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bioorg.2025.109058_bb0065","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1386-6346(03)00112-8","article-title":"ERK\/MAPK-dependent PI3K\/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells","volume":"26","author":"Takahashi","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bioorg.2025.109058_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phrs.2018.08.023","article-title":"Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors","volume":"136","author":"Lacal","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2025.109058_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041388","article-title":"Role of VEGFs\/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models","volume":"21","author":"Ceci","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109058_bb0080","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.21865","article-title":"The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma","volume":"119","author":"Wu","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.109058_bb0085","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/sj.bjc.6603143","article-title":"Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases","volume":"94","author":"Lesslie","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.109058_bb0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00595-014-0886-4","article-title":"The soluble VEGFR1 concentration in the serum of patients with colorectal cancer","volume":"45","author":"Abbasi","year":"2015","journal-title":"Surg. Today"},{"key":"10.1016\/j.bioorg.2025.109058_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/01.cad.0000361534.44052.c5","article-title":"Understanding the molecular-based mechanism of action of the tyrosine kinase inhibitor: Sunitinib","volume":"21","author":"Carrato Mena","year":"2010","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.bioorg.2025.109058_bb0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00280-012-1846-6","article-title":"An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors","volume":"69","author":"Asahina","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109058_bb0105","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2217\/fon-2020-0443","article-title":"Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma","volume":"16","author":"Jacob","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.bioorg.2025.109058_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020299","article-title":"Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective","volume":"16","author":"Kumar","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.109058_bb0115","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.3390\/molecules18066620","article-title":"Biomedical importance of indoles","volume":"18","author":"Kaushik","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109058_bb0120","doi-asserted-by":"crossref","first-page":"16852","DOI":"10.3390\/molecules200916852","article-title":"Heterocyclic anticancer compounds: recent advances and the paradigm shift towards the use of nanomedicine\u2019s tool box","volume":"20","author":"Martins","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109058_bb0125","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.apsb.2022.03.021","article-title":"Target-based anticancer indole derivatives and insight into structure\u2013activity relationship: a mechanistic review update (2018\u20132021)","volume":"12","author":"Dhiman","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109058_bb0130","article-title":"Approved small-molecule ATP-competitive kinases drugs containing indole\/Azaindole\/Oxindole scaffolds: R&D and binding patterns profiling","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109058_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21111525","article-title":"Synthesis of bisindole alkaloids from the Apocynaceae which contain a macroline or sarpagine unit: a review","volume":"21","author":"Rahman","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109058_bb0140","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.bmcl.2005.03.103","article-title":"New cytotoxic bisindole alkaloids with protein tyrosine kinase inhibitory activity from a myxomycete Lycogala epidendrum","volume":"15","author":"Hosoya","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109058_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmech.2018.02.065","article-title":"Indole in the target-based design of anticancer agents: a versatile scaffold with diverse mechanisms","volume":"150","author":"Dadashpour","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109058_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000092","article-title":"Anticancer activity of bisindole alkaloids derived from natural sources and synthetic bisindole hybrids","volume":"353","author":"Zhang","year":"2020","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.109058_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/md17100551","article-title":"Double the chemistry, double the fun: structural diversity and biological activity of marine-derived diketopiperazine dimers","volume":"17","author":"Gomes","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2025.109058_bb0160","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.drudis.2009.08.004","article-title":"Dihydropyridines: evaluation of their current and future pharmacological applications","volume":"14","author":"Edraki","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109058_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2024.100210","article-title":"Advances in synthesis, medicinal properties and biomedical applications of pyridine derivatives: a comprehensive review","volume":"12","author":"Sahu","year":"2024","journal-title":"European Journal of Medicinal Chemistry Reports"},{"key":"10.1016\/j.bioorg.2025.109058_bb0170","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1021\/jm100762r","article-title":"Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore","volume":"53","author":"Fleming","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109058_bb0175","series-title":"Principles of Toxicology: Environmental and Industrial Applications","author":"Williams","year":"2003"},{"key":"10.1016\/j.bioorg.2025.109058_bb0180","first-page":"549","article-title":"Solvent-free organic reaction techniques as an approach for Green chemistry, journal of the Turkish chemical society, section a","volume":"10","author":"Younis","year":"2023","journal-title":"Chemistry"},{"key":"10.1016\/j.bioorg.2025.109058_bb0185","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acsmedchemlett.9b00194","article-title":"Rigidification dramatically improves inhibitor selectivity for RAF kinases","volume":"10","author":"Assadieskandar","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109058_bb0190","first-page":"873","article-title":"Synthesis and cytotoxicity evaluation of novel indole derivatives as potential anti-Cancer agents","volume":"15","author":"Kamel","year":"2019","journal-title":"Med Chem (Los Angeles)"},{"key":"10.1016\/j.bioorg.2025.109058_bb0195","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1080\/10406638.2022.2128830","article-title":"A new approach for the synthesis of Bis(3-Indolyl)pyridines via a cooperative Vinylogous anomeric based oxidation using ammonium acetate as a dual reagent-catalyst role under mild and Green condition","volume":"43","author":"Sepehrmansourie","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.bioorg.2025.109058_bb0200","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/j.ejmech.2011.09.026","article-title":"Hantzsch reaction: synthesis and characterization of some new 1,4-dihydropyridine derivatives as potent antimicrobial and antioxidant agents","volume":"46","author":"Vijesh","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109058_bb0205","first-page":"2515","article-title":"Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production","volume":"51","author":"Vistica","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109058_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin\u2014an agent with multiple mechanisms of anticancer activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2025.109058_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/md17090536","article-title":"Synergistic cytotoxicity of renieramycin M and doxorubicin in MCF-7 breast cancer cells","volume":"17","author":"Tun","year":"2019","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2025.109058_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33665","article-title":"Flow cytometry-based quantitative analysis of cellular protein expression in apoptosis subpopulations: a protocol","volume":"10","author":"Alshehade","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2025.109058_bb0225","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10495-016-1323-5","article-title":"Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival","volume":"22","author":"Pu","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2025.109058_bb0230","series-title":"Down-Regulation of Caspase 3 in Breast cancer: A Possible Mechanism for Chemoresistance","author":"Devarajan","year":"2025"},{"key":"10.1016\/j.bioorg.2025.109058_bb0235","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.4c10809","article-title":"Antiangiogenic potential of beneficial sterols from Parotoid gland secretion of Indian common toads (Duttaphrynus melanostictus) in the coastal region of the Indian subcontinent: an in vivo to in silico approach","author":"Maji","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109058_bb0240","series-title":"Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays","author":"Mosmann","year":"1983"},{"key":"10.1016\/j.bioorg.2025.109058_bb0245","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.fitote.2008.06.007","article-title":"Cytotoxic activity screening of some indigenous Thai plants","volume":"79","author":"Prayong","year":"2008","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2025.109058_bb0250","series-title":"Over-Gene Expression in the Apoptotic, Oxidative Damage and Liver Injure in Female Rats Exposed to Butralin","author":"Refaie","year":"2025"},{"key":"10.1016\/j.bioorg.2025.109058_bb0255","author":"Fang"},{"key":"10.1016\/j.bioorg.2025.109058_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jsbmb.2018.06.006","article-title":"Novel pregnenolone derivatives modulate apoptosis via Bcl-2 family genes in hepatocellular carcinoma in vitro","volume":"183","author":"Elhinnawi","year":"2018","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.109058_bb0265","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1053\/j.gastro.2005.06.056","article-title":"CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer","volume":"129","author":"Saur","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bioorg.2025.109058_bb0270","doi-asserted-by":"crossref","unstructured":"T. Watanabe, T. Miura, Y. Degawa, Y. Fujita, M. Inoue, M. Kawaguchi, C. Furihata, Comparison of Lung cancer Cell Lines Representing Four Histopathological Subtypes with Gene Expression Profiling Using Quantitative Real-Time PCR, 2010. http:\/\/www.cancerci.com\/content\/10\/1\/2.","DOI":"10.1186\/1475-2867-10-2"},{"key":"10.1016\/j.bioorg.2025.109058_bb0275","first-page":"6071","article-title":"Gene expression profile comparison between colorectal cancer and adjacent normal tissues","volume":"14","author":"Yang","year":"2017","journal-title":"Oncol. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:10:39Z","timestamp":1763665839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":55,"alternative-id":["S0045206825009381"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109058","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 2,6-Bis(indolyl\/ 5-bromoindolyl)dihydropyridine\/pyridine hybrids as potential anti-tumor agents: Design, one-pot Green synthesis, molecular docking, and cytotoxicity evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109058"}}